Ying Song

Patent Agent

song-ying-300
  • JD, Trustee Academic Scholarship, with distinction in Business Law, Suffolk University Law School
  • PhD, Northwestern University
  • MS, University of Connecticut
  • BS, Northwest University, PR China

Qualifications

  • U.S. Patent and Trademark Office, Patent Agent, 2015

Ying Song

Patent Agent

Ying Song is a patent agent in the intellectual property transactions group. Ying’s practice includes helping clients with a wide range of IP issues, including patent portfolio development, patentability assessment, validity and freedom-to-operate analysis. Ying also assists in IP due diligence in the context of a range of transactions and litigation matters, including pre-litigation assessment, private financings, public offerings, licensing, and mergers and acquisitions. In addition, Ying has extensive experience with patent prosecution of small molecule pharmaceuticals, diagnostics and formulations.

Ying was originally trained as a synthetic chemist focusing on anticancer agents, diagnostic / imaging agents and drug delivery. Prior to joining the firm, Ying conducted her postdoctoral research at MIT, working on developing novel anticancer agents and studying their mechanism of action. Ying obtained her Ph.D. from Northwestern University where she worked on multimodal imaging agents, anticancer drugs and drug delivery via polymeric and nano scaffolds.

Publications

  • First author, “Multimodal Optical/MR Contrast Agents Based on Porphyrazines for Potential Cell Imaging,” Bioconjugate Chem, (2010)
  • First author, “Multimodal Gd-enriched DNA Gold Nanoparticle Conjugates for Cellular Imaging,” Angew.  Chem. (2009)
  • First author, “Synthesis and Characterization of Multimeric Contrast Agents for Cell MR Imaging,” J. Am. Chem. Soc. (2008)
  • Co-author, “Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformation,” ChemComm. (2014)
  • Co-author, “Phenanthriplatin, a Monofunctional, DNA-Binding Platinum Anticancer Drug Candidate with Unusual Potency and Cellular Activity Profile.”  Proc. Natl. Acad. Soc. (2012)
  • Co-author, “Modification of Embolic-PVA Particles with MR Contrast Agents,” Mag. Reson. Med. (2008)
  • JD, Trustee Academic Scholarship, with distinction in Business Law, Suffolk University Law School
  • PhD, Northwestern University
  • MS, University of Connecticut
  • BS, Northwest University, PR China

Qualifications

  • U.S. Patent and Trademark Office, Patent Agent, 2015
Cookie Settings